Andrew C Leon

Author PubWeight™ 119.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The NimStim set of facial expressions: judgments from untrained research participants. Psychiatry Res 2009 11.53
2 The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002 6.99
3 A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 2005 4.66
4 Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction 2003 4.25
5 A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003 3.59
6 Suicide among New York City police officers, 1977-1996. Am J Psychiatry 2002 3.51
7 Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry 2013 2.80
8 Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull 2006 2.53
9 Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry 2005 2.32
10 Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry 2010 2.18
11 Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug Alcohol Depend 2003 2.01
12 A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry 2007 1.93
13 Tachyphylaxis in unipolar major depressive disorder. J Clin Psychiatry 2005 1.67
14 The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003 1.63
15 A quality-based review of randomized controlled trials of psychodynamic psychotherapy. Am J Psychiatry 2010 1.62
16 ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology 2006 1.49
17 Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. J Clin Psychiatry 2016 1.43
18 Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry 2009 1.42
19 Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 2009 1.38
20 What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? Schizophr Bull 2008 1.38
21 A randomized trial of depression assessment intervention in home health care. J Am Geriatr Soc 2007 1.37
22 Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry 2009 1.35
23 Prevention of missing data in clinical research studies. Biol Psychiatry 2006 1.32
24 Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry 2008 1.31
25 Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. J Clin Psychopharmacol 2010 1.29
26 Statistical power and sample size requirements for three level hierarchical cluster randomized trials. Biometrics 2008 1.25
27 A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry 2009 1.24
28 Expanding the black box - depression, antidepressants, and the risk of suicide. N Engl J Med 2007 1.23
29 Sample size requirements to detect an intervention by time interaction in longitudinal cluster randomized clinical trials. Stat Med 2009 1.22
30 A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology 2007 1.13
31 Drugs and firearm deaths in New York City, 1990-1998. J Urban Health 2002 1.12
32 Does interpersonal loss preceding panic disorder onset moderate response to psychotherapy? An exploratory study. J Clin Psychiatry 2008 1.10
33 Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depress Anxiety 2009 1.10
34 Effects of anxiety on the long-term course of depressive disorders. Br J Psychiatry 2011 1.07
35 Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry 2010 1.06
36 Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design. Clin Trials 2009 1.06
37 Psychosocial impairment and recurrence of major depression. Compr Psychiatry 2004 1.04
38 Psychosocial interventions for late-life major depression: evidence-based treatments, predictors of treatment outcomes, and moderators of treatment effects. Psychiatr Clin North Am 2011 0.99
39 Distinguishing bipolar major depression from unipolar major depression with the screening assessment of depression-polarity (SAD-P). J Clin Psychiatry 2006 0.97
40 A controlled clinical treatment trial of interpersonal psychotherapy for depressed pregnant women at 3 New York City sites. J Clin Psychiatry 2013 0.95
41 Predicting recovery from episodes of major depression. J Affect Disord 2007 0.94
42 Performance of a mixed effects logistic regression model for binary outcomes with unequal cluster size. J Biopharm Stat 2005 0.93
43 The naturalistic course of unipolar major depression in the absence of somatic therapy. J Nerv Ment Dis 2006 0.93
44 Do comorbid personality disorders moderate panic-focused psychotherapy? An exploratory examination of the American Psychiatric Association practice guideline. J Clin Psychiatry 2007 0.93
45 Unipolar mania over the course of a 20-year follow-up study. Am J Psychiatry 2003 0.92
46 The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. J Clin Psychiatry 2008 0.92
47 Sample sizes required to detect two-way and three-way interactions involving slope differences in mixed-effects linear models. J Biopharm Stat 2010 0.91
48 The prospectively observed course of illness among depressed patients who commit suicide. Acta Psychiatr Scand 2002 0.90
49 A new scale for assessing the quality of randomized clinical trials of psychotherapy. Compr Psychiatry 2009 0.89
50 Role of antidepressants in murder and suicide. Am J Psychiatry 2002 0.89
51 Crisis of confidence: antidepressant risk versus benefit. J Clin Psychiatry 2011 0.89
52 Can interpersonal loss precipitate panic disorder? Am J Psychiatry 2004 0.88
53 The course of depression in elderly patients. Am J Geriatr Psychiatry 2004 0.88
54 Preference for fall from height as a method of suicide by elderly residents of New York City. Am J Public Health 2005 0.87
55 A new proposal for randomized start design to investigate disease-modifying therapies for Alzheimer disease. Clin Trials 2011 0.87
56 Antidepressant use in elderly suicide victims in New York city: an analysis of 255 cases. J Clin Psychiatry 2009 0.87
57 Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine. J Clin Psychiatry 2005 0.87
58 Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder. Clin Trials 2011 0.87
59 Comparison of statistical methods for analysis of clustered binary observations. Stat Med 2005 0.87
60 A randomized controlled trial of supported employment among veterans with posttraumatic stress disorder. Psychiatr Serv 2012 0.86
61 Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression. J Affect Disord 2010 0.85
62 Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder. Clin Trials 2013 0.84
63 Psychotherapies for Panic Disorder: A Tale of Two Sites. J Clin Psychiatry 2016 0.84
64 Empirical typology of bipolar I mood episodes. Br J Psychiatry 2009 0.84
65 Age of onset and the prospectively observed course of illness in bipolar disorder. J Affect Disord 2012 0.83
66 Are there differences in the symptoms that respond to a selective serotonin or norepinephrine reuptake inhibitor? Biol Psychiatry 2005 0.83
67 Integrating statistical and clinical research elements in intervention-related grant applications: summary from an NIMH workshop. Acad Psychiatry 2009 0.82
68 Psychopathology of panic attacks in panic disorder. J Affect Disord 2006 0.82
69 The face behind the mask: a developmental study. Dev Sci 2006 0.80
70 Antidepressant clinical trials and subject recruitment: just who are symptomatic volunteers? Am J Psychiatry 2011 0.79
71 Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials. Innov Clin Neurosci 2013 0.79
72 Use of treatment services in a comparative effectiveness study of bipolar disorder. Psychiatr Serv 2013 0.79
73 REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design. Psychopharmacol Bull 2008 0.79
74 Psychotherapies for panic disorder: a tale of two sites. J Clin Psychiatry 2015 0.79
75 Social problem solving and depressive symptoms over time: a randomized clinical trial of cognitive-behavioral analysis system of psychotherapy, brief supportive psychotherapy, and pharmacotherapy. J Consult Clin Psychol 2011 0.78
76 Symptoms of late-life depression: frequency and change during treatment. Am J Geriatr Psychiatry 2005 0.78
77 Assessment of outcome in depression. J Psychopharmacol 2006 0.78
78 Antidepressant treatment patterns in a novel methadone maintenance clinic targeting young adults an observational study. J Addict Dis 2006 0.77
79 Dysfunctional attitudes as a moderator of pharmacotherapy and psychotherapy for chronic depression. J Psychiatr Res 2012 0.76
80 The interactive computer interview for mania. Bipolar Disord 2010 0.76
81 Independent data and safety monitoring in psychiatric intervention research. J Clin Psychiatry 2012 0.75
82 Recovery from multiple episodes of bipolar I depression. J Clin Psychiatry 2013 0.75
83 Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders. J Clin Psychiatry 2014 0.75
84 "Gray murder": characteristics of elderly compared with nonelderly homicide victims in New York City. Am J Public Health 2007 0.75
85 The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research. J Psychiatr Res 2013 0.75
86 Suicidal overdoses of psychotropic drugs by elderly in New York City: comparison with younger adults. Psychiatry Res 2011 0.75